CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Jun. 28, 2026	Jun. 29, 2025	Jun. 28, 2026	Jun. 29, 2025
Revenues:
Equipment and services	$ 8,475	$ 8,893	$ 28,002	$ 28,193
Licensing	1,472	1,472	4,796	4,820
Total revenues	9,947	10,365	32,798	33,013
Costs and expenses:
Cost of revenues	4,670	4,606	15,138	14,704
Research and development	2,607	2,226	7,523	6,672
Selling, general and administrative	976	771	2,738	2,200
Other	68	0	97	0
Total costs and expenses	8,321	7,603	25,496	23,576
Operating income	1,626	2,762	7,302	9,437
Interest expense	(178)	(168)	(519)	(493)
Investment and other income, net	1,014	358	1,458	748
Income before income taxes	2,462	2,952	8,241	9,692
Income tax (expense) benefit	(460)	(286)	4,136	(1,034)
Net income	$ 2,002	$ 2,666	$ 12,377	$ 8,658
Basic earnings per share	$ 1.89	$ 2.44	$ 11.63	$ 7.85
Diluted earnings per share	$ 1.87	$ 2.43	$ 11.53	$ 7.79
Shares used in per share calculations:
Basic	1,057	1,092	1,064	1,102
Diluted	1,069	1,099	1,073	1,112

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Jun. 28, 2026	Jun. 29, 2025
Statement of Cash Flows [Abstract]
Net income	$ 12,377	$ 8,658
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	1,202	1,231
Income tax payments in excess of income tax provision	(5,550)	(1,535)
Share-based compensation expense	2,579	2,120
Net gains on marketable securities and other investments	(933)	(297)
Impairment losses on other investments	61	93
Equity in net earnings of investees	(149)	(13)
Other items	(52)	(10)
Changes in assets and liabilities:
Accounts receivable, net	(264)	535
Inventories	(1,798)	33
Other assets	777	361
Trade accounts payable	149	(220)
Payroll, benefits and other liabilities	231	(943)
Unearned revenues	(225)	3
Net cash provided by operating activities	8,405	10,016
Investing Activities:
Capital expenditures	(1,578)	(785)
Purchases of debt and equity marketable securities	(2,449)	(3,785)
Proceeds from sales and maturities of debt and equity marketable securities	3,896	4,892
Acquisitions and other investments, net of cash acquired	(1,573)	(711)
Proceeds from other investments	26	53
Other items	30	7
Net cash used by investing activities	(1,648)	(329)
Financing Activities:
Proceeds from short-term debt	3,238	998
Repayment of short-term debt	(2,743)	(998)
Repayment of debt of acquired company	(174)	0
Proceeds from long-term debt	0	1,487
Repayment of long-term debt	0	(1,365)
Proceeds from issuance of common stock	223	201
Repurchases and retirements of common stock	(6,806)	(6,347)
Dividends paid	(2,868)	(2,848)
Payments of tax withholdings related to vesting of share-based awards	(888)	(878)
Other items	(28)	(10)
Net cash used by financing activities	(10,046)	(9,760)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(21)	(5)
Net decrease in total cash, cash equivalents and restricted cash	(3,310)	(78)
Total cash and cash equivalents at beginning of period (including $2,323 classified as restricted cash at September 28, 2025)	7,843	7,849
Total cash and cash equivalents at end of period	4,533	$ 7,771
Beginning Balance - Restricted Cash	2,323
Ending Balance - Restricted Cash	$ 0

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) shares in Millions, $ in Millions	Jun. 28, 2026	Sep. 28, 2025
Current assets:
Cash and cash equivalents	$ 4,533	$ 5,520
Restricted cash	0	2,323
Marketable securities	3,771	4,635
Accounts receivable, net	4,668	4,315
Inventories	8,379	6,526
Other current assets	1,653	2,435
Total current assets	23,004	25,754
Deferred tax assets	5,679	743
Property, plant and equipment, net	5,217	4,690
Goodwill	14,274	11,358
Other intangible assets, net	1,510	1,148
Other assets	7,683	6,450
Total assets	57,367	50,143
Current liabilities:
Trade accounts payable	2,897	2,791
Payroll and other benefits related liabilities	1,470	1,839
Unearned revenues	280	358
Short-term debt	2,489	0
Other current liabilities	4,277	4,156
Total current liabilities	11,413	9,144
Unearned revenues	81	71
Long-term debt	12,781	14,811
Other liabilities	5,434	4,911
Total liabilities	29,709	28,937
Commitments and contingencies (Note 5)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 8 shares authorized; none outstanding	$ 0	$ 0
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	8	8
Preferred stock, shares outstanding	0	0
Common stock and paid-in capital, $0.0001 par value; 6,000 shares authorized; 1,057 and 1,074 shares issued and outstanding, respectively	$ 0	$ 0
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	6,000	6,000
Common stock, shares, issued	1,057	1,074
Common stock, shares, outstanding	1,057	1,074
Retained earnings	$ 27,263	$ 20,646
Accumulated other comprehensive income	395	560
Total stockholders’ equity	27,658	21,206
Total liabilities and stockholders’ equity	$ 57,367	$ 50,143